feed,title,long_url,short_url
Benzinga,Equillium's Itolizumab Shows Durable Clinical Response In GvHD Patients,https://benzinga.com/general/biotech/22/03/26259706/equilliums-itolizumab-shows-durable-clinical-response-in-gvhd-patients,https://bit.ly/3IEcI0x
Benzinga,AYRO Clocks 67% Revenue Growth In FY21,https://benzinga.com/news/earnings/22/03/26260595/ayro-clocks-67-revenue-growth-in-fy21,https://bit.ly/3irpjtA
